Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide.

Morandi, P; Ruffini, P A; Benvenuto, G M; La Vecchia, L; Mezzena, G; Raimondi, R

Morandi, P; Ruffini, P A; Benvenuto, G M; La Vecchia, L; Mezzena, G; Raimondi, R.

Affiliation

Morandi P; Division of Medical Oncology, San Bortolo Hospital, Vicenza, Italy.

Bone Marrow Transplant ; 28(3): 277-82, 2001 Aug.

Article in En | MEDLINE | ID: mdl-11535996

Subject(s)

Antineoplastic Agents, Alkylating/toxicity; Breast Neoplasms/drug therapy; Cyclophosphamide/toxicity; Electrocardiography/drug effects; Troponin I/blood; Adult; Antineoplastic Agents, Alkylating/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Biomarkers/blood; Breast Neoplasms/complications; Cyclophosphamide/administration & dosage; Dose-Response Relationship, Drug; Female; Heart Diseases/blood; Heart Diseases/chemically induced; Heart Diseases/diagnosis; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Middle Aged; Transplantation, Autologous/adverse effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Agents, Alkylating / Troponin I / Cyclophosphamide / Electrocardiography Type of study: Diagnostic_studies / Guideline Limits: Adult / Female / Humans / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2001 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links